Brief: Microport Cardioflow Medtech Sees HY Net Loss (Unaudited) Of RMB120 Mln To RMB135 Mln
05/08/2022 16:30
Aug 5 (Reuters) - Microport Cardioflow Medtech Corp
2160.HK :
* SEES NET LOSS (UNAUDITED) OF RMB120 MILLION TO RMB135
MILLION
FOR SIX MONTHS
* EXPECTED INCREASE IN REVENUE DUE TO CONTINUED
COMMERCIALIZATION
OF VITAFLOW AND VITAFLOW LIBERTY, AMONG OTHERS
Further company coverage: 2160.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MicroPort CardioFlow Medtech
See all newsBrief: Microport Cardioflow Medtech Posts FY Revenue Of $57 Million
Brief: Microport Cardioflow Medtech Proposes Share Consolidation
Brief: Microport Cardioflow Medtech Says Zhao Liang And Yan Luying Resign As Executive Directors
Brief: Microport Scientific Corp Says Microport Cardioflow Will Acquire CRM Cayman
Brief: Microport Cardioflow Medtech Corp Says Alwide Plus Balloon Catheter Receives CE Mark Approval